Abattis Biologix Corporation announced that it has terminated its prior agreement with the Hensley Group Inc. dated October 8, 2010 pursuant to which it had been granted the exclusive license to make, have made, use and sell the nutraceutical anti-viral nasal spray product code named ZITEK.